Federal Register / Vol. 89, No. 198 / Friday, October 11, 2024 / Notices 82629 

Production Act of 1993, 15 U.S.C. 4301 

et seq. (‘‘the Act’’), Biopharmaceutical 

Manufacturing Preparedness 

Consortium (‘‘BioMaP-Consortium’’) has 

filed written notifications 

simultaneously with the Attorney 

General and the Federal Trade 

Commission disclosing changes in its 

membership. The notifications were 

filed for the purpose of extending the 

Act’s provisions limiting the recovery of 

antitrust plaintiffs to actual damages 

under specified circumstances. 

Specifically, Arena BioPharma 

Consulting LLC, Athens, GA; 

ReechPharma LLC, Newark, CA; 

Repligen Corp., Waltham, WA; RexSter 

Technologies, Inc., Acton, MA; VJ 

Technologies, Inc., Bohemia, NY; Altor 

Safety LLC, Valley Cottage, NY; Anverra 

Pharma LLC, Mt. Pleasant, SC; Arranat 

Bio MA LLC, Watertown, MA; 

BioTechnique LLC, York, PA; Celltheon, 

Union City, CA; CHO Plus, Inc., South 

San Francisco, CA; Cocoon Bioscience 

S.L., Derio, SPAIN; CONTINUUS 

Pharmaceuticals, Inc., Woburn, MA; 

Convergence, Oklahoma City, OK; DNA 

Script, Daly City, CA; Evonik Corp., 

Piscataway, NJ; Gerresheimer Glass, 

Inc., Vineland, NJ; Innoviva Specialty 

Therapeutics, Waltham, MA; KBI 

Biopharma, Durham, NC; Orexo AB, 

Morristown, NJ; Persist AI Formulations 

Corp., West Sacramento, CA; Phenom 

Pharmaceuticals LLC, Miami Beach, FL; 

Shionogi, Inc., Florham Park, NJ; Solaris 

Vaccines, Inc., Fort Collins, CO; Spring 

Discovery, Inc., San Carlos, CA; Sublime 

LLC, Ann Arbor, MI, Watson-Marlow, 

Inc., Wilmington, MA; Apotex Corp., 

Weston, FL; Avid Bioservices, Inc., 

Tustin, CA; Burrell International Group 

LLC, Washington, DC; Dark Wolf 

Solutions LLC, Herdon, VA; 

GENEVATIONUS LLC, Sacramento, CA; 

Gusmer Enterprises, Inc., Mountainside, 

NJ; Integrated Pharma Services, 

Rockville, MD; Replicate Bioscience, 

San Diego, CA; Seqirus, Inc., Holly 

Springs, NC; Signet Healthcare 

Management LLC, New York, NY; 

Sterigenics Radiation Technologies LLC, 

Oak Brook, IL; The Albert B. Sabin 

Vaccine Institute, Inc., Washington, DC; 

Virica Biotech, Ottawa, CANADA; Agile 

GxP Technologies, Providence, RI; 

Allied Technologies and Consulting 

LLC, Frederick, MD; Global Key 

Solutions Corp., Dalton, PA; Industrial 

Info Resources, Inc., Sugar Land, TX; 

Prince Sterilization Services LLC, Pine 

Brook, NJ; Curia Global, Inc., Albany, 

NY; Donaldson Company, Inc., 

Bloomington, MN; GCM Pharma, St. 

Louis, MO; Photosynthetic B.V., 

Amsterdam, NETHERLANDS; 

Revagenix, Inc., San Francisco, CA; 

Agno Pharmaceuticals LLC, Bethlehem, 

PA; BioAnalysis LLC, Philadelphia, PA; 

Cornerstone Government Affairs, Inc., 

Washington, DC; Cytophage 

Technologies, Inc., Winnipeg, 

CANADA; Humanetics Corp., Edina, 

MN; NorthX Biologics AB, Matfors, 

SWEDEN; Novavax, Inc., Gaithersburg, 

MD; Quantiscope PBC, Salt Lake City, 

UT; Stoic Bio, Inc., San Diego, CA; and 

Sunflower Therapeutics PBC, Hingham, 

MA, have been added as parties to this 

venture. 

Also, Quantum Four Labs LLC, 

Arcadia, CA, has withdrawn as party to 

this venture. 

No other changes have been made in 

either the membership or planned 

activity of the group research project. 

Membership in this group research 

project remains open, and the BioMaPConsortium intends to file additional 

written notifications disclosing all 

changes in membership. 

On January 5, 2024, the BioMaPConsortium filed its original notification 

pursuant to section 6(a) of the Act. The 

Department of Justice published a notice 

in the Federal Register pursuant to 

section 6(b) of the Act on April 16, 2024 

(89 FR 26923). 

The last notification was filed with 

the Department on April 12, 2024. A 

notice was published in the Federal 

Register pursuant to section 6(b) of the 

Act on June 21, 2024 (89 FR 52097). 

Suzanne Morris, 

Deputy Director Civil Enforcement 

Operations, Antitrust Division. 

[FR Doc. 2024–23597 Filed 10–10–24; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF JUSTICE 

Antitrust Division 

Notice Pursuant to the National 

Cooperative Research and Production 

Act of 1993—PXI Systems Alliance, 

Inc. 

Notice is hereby given that, on August 

2, 2024, pursuant to section 6(a) of the 

National Cooperative Research and 

Production Act of 1993, 15 U.S.C. 4301 

et seq. (‘‘the Act’’), PXI Systems 

Alliance, Inc. (‘‘PXI Systems’’) has filed 

written notifications simultaneously 

with the Attorney General and the 

Federal Trade Commission disclosing 

changes in its membership. The 

notifications were filed for the purpose 

of extending the Act’s provisions 

limiting the recovery of antitrust 

plaintiffs to actual damages under 

specified circumstances. Specifically, 

Wuhan Pusaisi Electronics Co., Ltd 

(Pultiwave), Wuhan City, PEOPLE’S 

REPUBLIC OF CHINA, has been added 

as a party to this venture. 

No other changes have been made in 

either the membership or planned 

activity of the group research project. 

Membership in this group research 

project remains open, and PXI Systems 

intends to file additional written 

notifications disclosing all changes in 

membership. 

On November 22, 2000, PXI Systems 

filed its original notification pursuant to 

section 6(a) of the Act. The Department 

of Justice published a notice in the 

Federal Register pursuant to section 

6(b) of the Act on March 8, 2001 (66 FR 

13971). 

The last notification was filed with 

the Department on May 23, 2024. A 

notice was published in the Federal 

Register pursuant to section 6(b) of the 

Act on June 24, 2024 (89 FR 52508). 

Suzanne Morris, 

Deputy Director Civil Enforcement 

Operations, Antitrust Division. 

[FR Doc. 2024–23615 Filed 10–10–24; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF JUSTICE 

Antitrust Division 

Notice Pursuant to the National 

Cooperative Research and Production 

Act of 1993—Consortium for Rare 

Earth Technologies 

Notice is hereby given that, on July 

18, 2024, pursuant to section 6(a) of the 

National Cooperative Research and 

Production Act of 1993, 15 U.S.C. 4301 

et seq. (‘‘the Act’’), Consortium for Rare 

Earth Technologies (‘‘CREaTe’’) has 

filed written notifications 

simultaneously with the Attorney 

General and the Federal Trade 

Commission disclosing changes in its 

membership. The notifications were 

filed for the purpose of extending the 

Act’s provisions limiting the recovery of 

antitrust plaintiffs to actual damages 

under specified circumstances. 

Specifically, Watts & Fisher Pty Ltd, 

Mandurah, WA; Alkemio, San 

Francisco, CA; Fluid Photonics 

Corporation, Lindenhurst, NY; MTL 

Corp., Bloomington, MN; and Precision 

Combustion, Inc., North Haven, CT, 

have been added as parties to this 

venture. 

No other changes have been made in 

either the membership or planned 

activity of the group research project. 

Membership in this group research 

project remains open, and CREaTe 

intends to file additional written 

notifications disclosing all changes in 

membership. 


ddrumheller on DSK120RN23PROD with NOTICES1
82630 Federal Register / Vol. 89, No. 198 / Friday, October 11, 2024 / Notices 

On April 22, 2022, CREaTe filed its 

original notification pursuant to section 

6(a) of the Act. The Department of 

Justice published a notice in the Federal 

Register pursuant to section 6(b) of the 

Act on May 13, 2022 (87 FR 29384). 

The last notification was filed with 

the Department on April 12, 2024. A 

notice was published in the Federal 

Register pursuant to section 6(b) of the 

Act on June 28, 2024 (89 FR 54042). 

Suzanne Morris, 

Deputy Director Civil Enforcement 

Operations, Antitrust Division. 

[FR Doc. 2024–23599 Filed 10–10–24; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF JUSTICE 

Antitrust Division 

Notice Pursuant to the National 

Cooperative Research and Production 

Act of 1993—R Consortium, Inc. 

Notice is hereby given that, on 

September 23, 2024, pursuant to section 

6(a) of the National Cooperative 

Research and Production Act of 1993, 

15 U.S.C. 4301 et seq. (‘‘the Act’’), R 

Consortium, Inc. (‘‘R Consortium’’) has 

filed written notifications 

simultaneously with the Attorney 

General and the Federal Trade 

Commission disclosing changes in its 

membership. The notifications were 

filed for the purpose of extending the 

Act’s provisions limiting the recovery of 

antitrust plaintiffs to actual damages 

under specified circumstances. 

Specifically, Novartis, Hanover, NJ, has 

been added as a party to this venture. 

No other changes have been made in 

either the membership or planned 

activity of the group research project. 

Membership in this group research 

project remains open, and R Consortium 

intends to file additional written 

notifications disclosing all changes in 

membership. 

On September 15, 2015, R Consortium 

filed its original notification pursuant to 

section 6(a) of the Act. The Department 

of Justice published a notice in the 

Federal Register pursuant to section 

6(b) of the Act on October 2, 2015 (80 

FR 59815). 

The last notification was filed with 

the Department on April 22, 2024. A 

notice was published in the Federal 

Register pursuant to section 6(b) of the 

Act on June 21, 2024 (89 FR 52090). 

Suzanne Morris, 

Deputy Director Civil Enforcement 

Operations, Antitrust Division. 

[FR Doc. 2024–23625 Filed 10–10–24; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF JUSTICE 

Antitrust Division 

Notice Pursuant to the National 

Cooperative Research and Production 

Act of 1993—Silicon Integration 

Initiative, Inc. 

Notice is hereby given that, on July 

24, 2024, pursuant to section 6(a) of the 

National Cooperative Research and 

Production Act of 1993, 15 U.S.C. 4301 

et seq. (‘‘the Act’’), Silicon Integration 

Initiative, Inc. (‘‘Si2’’) has filed written 

notifications simultaneously with the 

Attorney General and the Federal Trade 

Commission disclosing changes in its 

membership. The notifications were 

filed for the purpose of extending the 

Act’s provisions limiting the recovery of 

antitrust plaintiffs to actual damages 

under specified circumstances. 

Specifically, Vaire Computing Ltd, 

London, UNITED KINGDOM; Simple 

EDA Global Services OU ̈ , Aaspere, 

ESTONIA; Moore Threads Inc., San 

Diego, CA; Enable Design System, Inc., 

Seoul, REPUBLIC OF KOREA; and D2S, 

Inc., San Jose, CA, have been added as 

parties to this venture. 

Also, Intento Design S.A.S, Paris, 

FRANCE; United Semiconductor Japan 

Co., Ltd, Yokohama, JAPAN; Raon 

Solution, Ochang-eup, REPUBLIC OF 

KOREA; Silicon Technologies Inc., 

Midvale, UT; Semiconductor 

Components Industries, LLC, DBA ON 

Semiconductor Corporation (onsemi), 

Phoenix, AZ; and Raytheon Company, 

Plano, TX, have withdrawn as parties to 

this venture. 

Additionally, the following members 

have changed their names: Analog Rails, 

Tempe, AZ, to Western Semiconductor; 

HW21, San Francisco, CA, to Generation 

Alpha (GenAlpha). 

Finally, Cadence Design Systems, 

Inc., Bracknell, UNITED KINGDOM, has 

purchased Pulsic, Ltd. 

No other changes have been made in 

either the membership or planned 

activity of the group research project. 

Membership in this group research 

project remains open, and Si2 intends to 

file additional written notifications 

disclosing all changes in membership. 

On December 30, 1988, Si2 filed its 

original notification pursuant to section 

6(a) of the Act. The Department of 

Justice published a notice in the Federal 

Register pursuant to section 6(b) of the 

Act on March 13, 1989 (54 FR 10456). 

The last notification was filed with 

the Department on July 19, 2023. A 

notice was published in the Federal 

Register pursuant to section 6(b) of the 

Act on October 5, 2023 (88 FR 69234). 

Suzanne Morris, 

Deputy Director Civil Enforcement 

Operations, Antitrust Division. 

[FR Doc. 2024–23614 Filed 10–10–24; 8:45 am] 

BILLING CODE 4410–11–P 

DEPARTMENT OF JUSTICE 

Antitrust Division 

Notice Pursuant to the National 

Cooperative Research and Production 

Act of 1993—Bytecode Alliance 

Foundation 

Notice is hereby given that, on August 

12, 2024, pursuant to section 6(a) of the 

National Cooperative Research and 

Production Act of 1993, 15 U.S.C. 4301 

et seq. (‘‘the Act’’), Bytecode Alliance 

Foundation has filed written 

notifications simultaneously with the 

Attorney General and the Federal Trade 

Commission disclosing changes in its 

membership. The notifications were 

filed for the purpose of extending the 

Act’s provisions limiting the recovery of 

antitrust plaintiffs to actual damages 

under specified circumstances. 

Specifically, Interuniversitair MicroElectronica Centrum vzw, Leuven, 

BELGIUM, has been added as a party to 

this venture. 

No other changes have been made in 

either the membership or planned 

activity of the group research project. 

Membership in this group research 

project remains open, and Bytecode 

Alliance Foundation intends to file 

additional written notifications 

disclosing all changes in membership. 

On April 20, 2022, Bytecode Alliance 

Foundation filed its original notification 

pursuant to section 6(a) of the Act. The 

Department of Justice published a notice 

in the Federal Register pursuant to 

section 6(b) of the Act on May 13, 2022 

(87 FR 29379). 

The last notification was filed with 

the Department on June 6, 2024. A 

notice was published in the Federal 

Register pursuant to section 6(b) of the 

Act on June 24, 2024 (89 FR 52509). 

Suzanne Morris, 

Deputy Director Civil Enforcement 

Operations, Antitrust Division. 

[FR Doc. 2024–23622 Filed 10–10–24; 8:45 am] 

BILLING CODE P 


ddrumheller on DSK120RN23PROD with NOTICES1